| Value | ₹0.02 Cr |
|---|---|
| Execution period | 3 years from vesting |
NSE filing, NSE: VALIANTORG. Summary written from the filing by ALFA Finder's alert engine.
Valiant Organics Ltd: key numbers
- Share price
- ₹456.20
- Market cap
- ₹1,279 Cr
- Revenue (annual)
- ₹738.8 Cr
- Net profit (annual)
- ₹33.24 Cr
- P/E (TTM)
- 23.6×Sector 34.1×
- Promoter holding
- 37.89%+0.02% QoQ
- FII holding
- 0.44%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Valiant Organics Ltd
All →Valiant Organics Other Announcement
The company has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.
Valiant Organics Legal & Regulatory
Valiant Organics received an income tax rectification order for Assessment Year 2015-16, determining a net payable amount of ₹0.22 Crore.
- Value
- ₹0.22 Cr
Valiant Organics Investor Presentation: Key Takeaways
Valiant Organics presented its FY26 performance at the AGM, reporting Revenue of INR 739 Cr and EBITDA margin of 13.64%. The firm is shifting focus towards high-margin Benzene and Chlorophenol derivatives.
Valiant Organics Annual General Meeting
Valiant Organics held its 21st AGM on September 29, 2026, transacting various ordinary and special business items including re-appointments and material related party transaction approvals.
Valiant Organics Promoter Buying: ₹0 Cr
Promoter Vicky Hemchand Gala purchased 3,500 shares of Valiant Organics via a market transaction. This increases the promoter's stake by 0.01%.
- Value
- ₹0.00 Cr
- Promoter stake change
- +0.01%
Valiant Organics Promoter Buying: ₹0.13 Cr
Promoter Vicky Hemchand Gala acquired 3,500 shares of Valiant Organics Ltd via a market purchase. This increases the promoter's holding from 0.92% to 0.93%.
- Value
- ₹0.13 Cr
- Promoter stake change
- +0.01%
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date